Internal Dispute Resolution Process Encourages Use Of Outside Experts
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's internal dispute resolution policy encourages use of outside experts wherever feasible
You may also be interested in...
Drug Safety Oversight Board Will Require Two-Thirds Majority For Recommendations
FDA's Drug Safety Oversight Board will need a two-thirds majority of a quorum to make recommendations, a Center for Drug Evaluation & Research Manual of Policies & Procedures states
Drug Safety Oversight Board Will Require Two-Thirds Majority For Recommendations
FDA's Drug Safety Oversight Board will need a two-thirds majority of a quorum to make recommendations, a Center for Drug Evaluation & Research Manual of Policies & Procedures states
FDA Product Jurisdiction Review Requests Nearly Double
Request designations, which mostly involve drug/device combinations, grew at a higher rate than the overall number of contacts with the CDER ombudsman. Phone calls also ballooned in 2004. "Hot topics" include importation, Plan B and drug safety.